Microbot Medical Inc.
MBOT- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0000883975
No open-market purchases or sales by Microbot Medical Inc. insiders were filed in the last 90 days; 71 institutions reported holding it in 13F filings for Q2 2026, worth $22.1M in total; no superinvestor holds it.
Q3 2025 vs. Q2 2025
How the institutions holding Microbot Medical Inc. changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Q3 2025 | Change |
|---|---|---|---|
| Holders | 50 | 68 | +18 |
| Shares | 4.39M | 8.97M | +4.58M (+104.4%) |
| Value | $11.1M | $27.4M | +$16.3M (+147.5%) |
New holders (27)
Institutions that held Microbot Medical Inc. at the end of Q3 2025 but not at the end of Q2 2025.
Sold out (9)
Institutions that held Microbot Medical Inc. at the end of Q2 2025 and filed for Q3 2025 without it.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| Goldman Sachs Group Inc | 34,003 | $85.7K |
| XTX Topco Ltd | 17,179 | $43.3K |
| Citigroup Inc | 14,042 | $35.4K |
| American Century Companies Inc | 12,710 | $32.0K |
| Caitong International Asset Management Co., Ltd | 3,273 | $8.25K |
| Transce3nd, LLC | 330 | $832 |
| Raymond James Financial Inc | 14 | $36 |
| Garde Capital, Inc. | 2 | $6 |
| Larson Financial Group LLC | 1 | $3 |